Results

1–10 of 15 results for methotrexate

Postoperative Methotrexate Injections Decrease Reoperation Rate and Improve Vision Following Vitrectomy for PDR and Complex Retinal Detachments
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2025
Intravitreal Methotrexate for the Treatment and Prevention of Proliferative Vitreoretinopathy in Pediatric Patients
Philip J. Ferrone, MD, FASRS
Annual Meeting Talks
2025
Interim Report of the FIXER Trial: Prevention of ProliFerative Vitreoretinopathy With Intravitreal MethotreXate in Primary Retinal DEtachment Repair
Christopher D. Riemann, MD
Annual Meeting Talks
2025
Outcomes of Complex PVR Retinal Detachment Repair with and without Intravitreal Methotrexate at a Single Tertiary Care Center
John B. Miller, MD
Updates from the Field
2026
Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications
Christina Joy Flaxel, MD
Annual Meeting Talks
2023
Expert Panel: PVR
Christina Y Weng, MD, MBA, FASRS
Lejla Vajzovic, MD, FASRS
Isabela Martins Melo, MD
Sarah Syeda, MD
Prashant Keshao Bawankule, M.S.
Leo A. Kim, MD, PhD
Annual Meeting Talks
2024
Postoperative Methotrexate Reduces Reoperations and Improves Vision After Vitrectomy for Proliferative Diabetic Retinopathy
Alan J. Franklin, MD, PhD
Updates from the Field
2025
Intravitreal Methotrexate Reduces Reoperation Rate and Improves Vision After Vitrectomy for Retinal Detachment, Trauma, and Proliferative Diabetic Retinopathy
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2022
Oral Methotrexate as a Method of Preventing Proliferative Vitreoretinopathy
On Demand Cases, Courses, and Papers
2022
Methotrexate Bubble following Intravitreal Injection for PVR
Zach Seim
Retina Image Bank: Images of the Week
2022